Acadia Healthcare (ACHC)
(Delayed Data from NSDQ)
$81.93 USD
+1.08 (1.34%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $81.98 +0.05 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Income Statements
Fiscal Year end for Acadia Healthcare Company, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,929 | 2,610 | 2,314 | 2,090 | 3,107 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 2,929 | 2,610 | 2,314 | 2,090 | 3,107 |
Selling & Adminstrative & Depr. & Amort Expenses | 2,416 | 2,143 | 1,900 | 1,724 | 2,703 |
Income After Depreciation & Amortization | 513 | 468 | 414 | 366 | 405 |
Non-Operating Income | -456 | -24 | -62 | -24 | -81 |
Interest Expense | 82 | 70 | 77 | 158 | 187 |
Pretax Income | -25 | 374 | 276 | 184 | 136 |
Income Taxes | -10 | 94 | 68 | 41 | 26 |
Minority Interest | 6 | 7 | 5 | 3 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -16 | 280 | 208 | 143 | 110 |
Extras & Discontinued Operations | 0 | 0 | -13 | -812 | 0 |
Net Income (GAAP) | -22 | 273 | 191 | -672 | 109 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 649 | 589 | 525 | 473 | 581 |
Depreciation & Amortization (Cash Flow) | 136 | 121 | 111 | 108 | 176 |
Income After Depreciation & Amortization | 513 | 468 | 414 | 366 | 405 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 90.95 | 91.56 | 90.79 | 88.60 | 87.82 |
Diluted EPS Before Non-Recurring Items | 3.44 | 3.01 | 2.56 | 2.78 | 2.04 |
Diluted Net EPS (GAAP) | -0.24 | 2.98 | 2.10 | -7.59 | 1.24 |
Fiscal Year end for Acadia Healthcare Company, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 796.04 | 768.05 | 742.80 | 750.33 | 731.34 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 796.04 | 768.05 | 742.80 | 750.33 | 731.34 |
SG&A, R&D, and Dept/Amort Expenses | 653.33 | 639.15 | 615.78 | 611.56 | 596.23 |
Income After SG&A, R&D, and Dept/Amort Expenses | 142.71 | 128.90 | 127.02 | 138.77 | 135.11 |
Non-Operating Income | -7.09 | -2.85 | -36.33 | -405.43 | -17.77 |
Interest Expense | 29.16 | 27.21 | 20.47 | 20.74 | 20.91 |
Pretax Income | 106.46 | 98.84 | 79.97 | -287.40 | 96.43 |
Income Taxes | 25.64 | 20.07 | 20.21 | -71.87 | 22.88 |
Minority Interest | 2.34 | 2.39 | 2.03 | 2.19 | 1.25 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 80.82 | 78.77 | 59.76 | -215.53 | 73.55 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 78.48 | 76.38 | 57.73 | -217.71 | 72.30 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 92.04 | 92.01 | 91.87 | 91.17 | 91.55 |
Diluted EPS Before Non-Recurring Items | 0.91 | 0.84 | 0.85 | 0.91 | 0.92 |
Diluted Net EPS (GAAP) | 0.85 | 0.83 | 0.64 | -2.39 | 0.79 |